HomeEmerging MarketsMarkets Calm As Trump's...

Markets Calm As Trump’s July 9 Deadline Accelerates Diplomacy – AMG Critical Materials (OTC:AMVMF)

The July 9 deadline for the 90-day tariff pause is approaching as global trade diplomacy intensifies. While President Donald Trump evaluates options on reciprocal tariffs, nations across Asia and Europe are discussing deals that protect their interest, while balancing ties with both Washington and Beijing.

So far, the market shows no signs of anxiety, as the temporary tariff freeze, initiated in April, triggered one of the sharpest market rallies this year. The S&P 500 surged over 28% off April lows, driven by investor optimism that a broad global trade breakdown could be avoided.

The implied volatility VIX Index – a typical fear gauge which shows the implied market move over the next 30 days is below 16.75 as of Wednesday, July 2, near the yearly lows.

Trump’s Compliance Bucket

U.S. Commerce Secretary Howard Lutnick said last week that the administration is prepared to finalize deals with up to 10 major partners before the deadline.

“President Trump has made clear that if agreements aren’t reached in time, letters will be sent dictating terms,” Lutnick told Bloomberg. Countries, he added, would be “sorted into proper buckets” depending on their compliance with U.S. trade expectations.

One key goal of the U.S. is to limit Chinese content in supply chains. India, Vietnam, and Taiwan are under pressure to meet “rules of origin” thresholds, with Washington seeking at least 60% local value-added in traded goods. For many Asian economies, this poses a dilemma.

“Asia’s dilemma when it comes to Trump’s trade war is all about dependence on U.S. final demand while relying heavily on China’s value added in domestic production,” Alicia Garcia Herrero, chief Asia-Pacific economist at Natixis SA, said per AP News. She noted that Vietnam, Cambodia, and Taiwan are the most exposed.

European Industry Seeks Independence

Europe, meanwhile, finds itself walking a tightrope. The European Union is China’s largest export market for electric vehicles and has seen over €10 billion in Chinese investment last year. Yet, the EU faces a 50% tariff threat from the U.S. on nearly all its exports if a deal is not reached.

Former EU Chamber of Commerce President Joerg Wuttke captured Europe’s cautious stance: “The EU remains geared towards the U.S., but trade with China continues. We are not allies. We are trading partners,” he said for AP News.

However, the opinions of bureaucrats and industrialists vastly differ. Stefan Scherer, CEO of German lithium supplier AMG Lithium AMVMF, was more blunt.

“Europe has to become independent of China, otherwise it’s just blah blah blah,” he said for The Guardian, criticizing the EU’s reliance on Chinese critical raw materials. He argues that the EU is still years behind China in terms of dominance in key supply chains.

The EU’s recent efforts include a Critical Raw Materials Act and a €241 billion ($284 billion) investment in nuclear energy.

Bessent’s Warning To Brussels

Beijing, for its part, has warned it will not accept trade deals that harm its interests. “China firmly opposes any party reaching a deal at the expense of Chinese interests in exchange for so-called tariff reductions,” the Ministry of Commerce said, according to the JingDaily.

While the EU seeks to maintain its autonomy, Washington has cautioned against the growing ties between the EU and China. Treasury Secretary Scott Bessent warned, “Countries seeking to get closer to China would be cutting their own throat,” citing the risk of China dumping goods banned in the U.S. into Europe.

Still, Beijing is capitalizing on its moment. An EU-China summit scheduled for July 24-25 aims to reaffirm ties. Analysts believe China will use the meeting to demonstrate unity with Europe and counterbalance U.S. pressure. As Garcia noted, “China has built so many strategic dependencies that the EU is trapped in an asymmetric relationship.”

Read Next:

Photo: Shutterstock

Most Popular

More from Author

June Payrolls Jump, but Other Growth Indicators Paint a Sluggish Picture

June beats consensus on the back of education and health...

Fed Gets Breathing Room as Labor Market Holds Firm

The monthly jobs report hit today (unusually, on a Thursday, due...

How California’s Housing Reforms Could Reshape US Cities Over the Next Decade

Things are moving fast these days. Texans for Reasonable Solutions, among others,...

Week Ahead – RBA, RBNZ Decisions and Fed Minutes Eyed as Trade Deals Awaited

July 9 tariff deadline looms as trade deals remain elusive Fed minutes...

Read Now

June Payrolls Jump, but Other Growth Indicators Paint a Sluggish Picture

June beats consensus on the back of education and health services employment, while private NFP surprises downside. With S&P Global monthly flat over the last six months through May, many key indicators followed by the NBER  Business Cycle Dating Committee (BCDC) are flat or falling...

Fed Gets Breathing Room as Labor Market Holds Firm

The monthly jobs report hit today (unusually, on a Thursday, due to the real and perfectly sensible holiday tomorrow blocking the typical Friday release) and the reaction was immediate. All the equity futures remain strong, but paradoxically, it can sometimes be a spike to the upside that...

How California’s Housing Reforms Could Reshape US Cities Over the Next Decade

Things are moving fast these days. Texans for Reasonable Solutions, among others, has helped push through a number of housing reforms in Texas. Maine has passed a couple of bills that should allow more step-change urban development, as I put it in the “Market Segmentation” post. And California has suddenly...

Week Ahead – RBA, RBNZ Decisions and Fed Minutes Eyed as Trade Deals Awaited

July 9 tariff deadline looms as trade deals remain elusive Fed minutes to be watched after positive jobs report RBA expected to cut but RBNZ to likely stay on hold OPEC+ to probably raise output again UK GDP, Canadian employment and Chinese CPI data also on tap The Race to the Finish...

The Fiscal Treadmill Is Speeding Up and Washington Keeps Jogging

As of 1980, the rolling 10-year and 20-year real GDP growth rates stood at 3.2% per annum and 3.5% per annum, respectively. Owing to a slight boost from the good parts of Reaganomics—sweeping deregulation, tax rate cuts, and sound money, which were partially offset by the long-term ills...

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Immuthera's Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy SolutionsDistinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman have joined Immuthera's Scientific Advisory Board.Immuthera will continue expanding its Scientific Advisory Board over the coming months to build a truly world-class team.In collaboration...

Risk Assets Extend Gains but Low Volumes Could Skew Monday Open

Yesterday’s market action was driven by consecutive upside surprises in US (147K vs 110K exp) and data (50.8 vs 50.5 exp), fueling another wave of positive sentiment and pushing US equities into yet another frenzied rally. The reaction to the data was progressive but consistent, taking...

Risk-On Sentiment Fades as Tariffs Return to the Spotlight

Dollar surrenders gains posted after robust labour market report Trump celebrates US budget bill approval; scheduled to sign it today Most Fed members feel more comfortable as July rate cut is priced out Oil steadies near $66, gold rally retains momentum Thursday Proved to Be Rather EventfulWhile the US is celebrating...

Oil Prices Set to End the Week With a Modest Gain

prices were on course for a modest weekly gain today, buffeted by both headwinds and tailwinds, including OPEC+ policy, U.S. job numbers, and anticipation of President Trump’s next move on tariffs. At the time of writing, was trading at $68.58 per barrel, with West Texas Intermediate...

Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer’s Trial Data – Cognition Therapeutics (NASDAQ:CGTX), InMed Pharmaceuticals (NASDAQ:INM)

Cognition Therapeutics Inc CGTX rose 12.10% to $0.45 during after hours on Thursday, following a surge of 20.82% gain during regular hours. What Happened: The hike in Cognition Therapeutics’ stock price is attributed to the promising results from its Alzheimer’s drug, Zervimesine. The drug achieved a 95% efficacy...

Oil: How Traders Capitalized on Extreme Price Swings

The first half of the year saw significant oil price volatility influenced by U.S. trade policies, OPEC+ production decisions, and geopolitical tensions. Oil prices initially slumped due to new U.S. tariffs and increased OPEC+ output, leading traders to amass short positions. Prices later spiked in June due to Middle...

Gold Prices Slide as Strong NFP Data Undermines Fed Rate Cut Hopes

Strong NFP Data Put Downward Pressure on Gold Yesterday’s US (NFP) data showed that the labour market remains resilient, putting downward pressure on Gold (). In June, companies created more jobs than expected, and the unexpectedly dropped towards 4.1%. The overall report was better than expected, reducing...